Physician profile
Mark J Johnson
NPI 1740783554
$494.71
in general payments reported to CMS, 2019-2025
12 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.99 · 2021: $52.56 · 2022: $21.29 · 2023: $135 · 2024: $125 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $157.09 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $58.22 | 2024 | |
| Pfizer INC. | $46.99 | 2025 | |
| Boston Scientific Corporation | $39.90 | 2023 | |
| Exact Sciences Corporation | $34.48 | 2023-2024 | Cologuard Collection Kit |
| Abbott Laboratories | $33.55 | 2021 | |
| Averitas Pharma INC. | $25.25 | 2025 | Qutenza |
| Astrazeneca Pharmaceuticals LP | $22.11 | 2023 | Breztri |
| Daiichi Sankyo INC. | $21.29 | 2022 | |
| Nevro Corp. | $19.83 | 2023 | Senza |
| Abbvie INC. | $19.01 | 2021 | |
| Allergan, INC. | $16.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.